284 related articles for article (PubMed ID: 26518684)
1. Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.
Bonke FC; Donnachie E; Schneider A; Mehring M
Diabetologia; 2016 Feb; 59(2):286-93. PubMed ID: 26518684
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
3. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
[TBL] [Abstract][Full Text] [Related]
4. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
[TBL] [Abstract][Full Text] [Related]
5. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
6. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction for severe hypoglycemia in a type 2 diabetes population with previous non-severe hypoglycemia.
Misra-Hebert AD; Ji X; Pantalone KM; Hu B; Dey T; Milinovich A; Bauman JM; Zimmerman RS; Kattan MW
J Diabetes Complications; 2020 Jan; 34(1):107490. PubMed ID: 31757766
[TBL] [Abstract][Full Text] [Related]
8. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
Kulzer B; Seitz L; Kern W
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
[TBL] [Abstract][Full Text] [Related]
9. Severe hypoglycaemia in elderly patients with type 2 diabetes and coexistence of cardiovascular history.
Piątkiewicz P; Buraczewska-Leszczyńska B; Kuczerowski R; Bernat-Karpińska M; Rabijewski M; Kowrach M
Kardiol Pol; 2016; 74(8):779-785. PubMed ID: 27040016
[TBL] [Abstract][Full Text] [Related]
10. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
11. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
Ajjan RA; Jackson N; Thomson SA
Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
[TBL] [Abstract][Full Text] [Related]
12. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
13. Does hypoglycaemia affect the improvement in QoL after the transition to insulin in people with type 2 diabetes?
Wieringa TH; de Wit M; Twisk JWR; Snoek FJ
J Endocrinol Invest; 2018 Feb; 41(2):249-258. PubMed ID: 28803366
[TBL] [Abstract][Full Text] [Related]
14. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Kostev K; Dippel FW; Rathmann W
Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
[TBL] [Abstract][Full Text] [Related]
15. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.
Home PD; Dain MP; Freemantle N; Kawamori R; Pfohl M; Brette S; Pilorget V; Scherbaum WA; Vespasiani G; Vincent M; Balkau B
Diabetes Res Clin Pract; 2015 May; 108(2):350-9. PubMed ID: 25825361
[TBL] [Abstract][Full Text] [Related]
16. Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies.
Riddle MC; Vlajnic A; Zhou R; Rosenstock J
Diabetes Obes Metab; 2013 Sep; 15(9):819-25. PubMed ID: 23489438
[TBL] [Abstract][Full Text] [Related]
17. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-Visit HbA
Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
[TBL] [Abstract][Full Text] [Related]
19. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]